Dallas-based private equity firm Kainos has made a minority investment in BeautyBio. Founded in 2011 by Jamie O’Banion, BeautyBio is a leading prestige skincare brand dedicated to making high-tech skincare transparent and accessible. The company’s portfolio of clinically proven products disrupts traditional skincare, marrying topical skincare with clinical tools for a fully comprehensive skin health approach.

“They’re not a traditional beauty fund, which is something that I loved because we want to make sure we’re always meaningful to whoever we partner with,” O’Banion told WWD, referencing the firm’s current lack of other beauty investments. “Because we’re scaling right now it’s less about having someone that is able to make an introduction …What I need is someone who’s an operational expert.”

Terms of the deal were not disclosed, but according to WWD industry sources, BeautyBio is expected to double in 2019 to more than $100 million in sales.